Market Overview
The Global "DNA/RNA Extraction Kit Market" is expected to reach at a high CAGR during the forecast period (2024-2031). 168 pages report analyses the DNA/RNA Extraction Kit market shares, recent trends, competitive intelligence and future market outlook. DNA/RNA Extraction Kit usage in to detect and extract DNA/RNA from the sample is on the rise. Demand from pharmaceuticals & commercial infrastructure in ‘North America’ is booming. Competitive rivalry intensifies with Thermo Fisher Scientific Inc, Primerdesign, QIAGEN N.V., RevoluGen, Bioneer corp, BioFire Defense, General Biosystems and others operating in the market.
DNA and RNA extraction is a combination of chemical and physical processes involved in isolating DNA or RNA. Extraction by chemical method involves utilizing extraction kits to detect and extract DNA/RNA from the sample. Extraction kits simplify extraction by eliminating the need for mechanical disruption and decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high-quality DNA/RNA.
Market Summary
Metrics | Details |
CAGR | High |
Size Available for Years | 2022-2031 |
Forecast Period | 2024-2031 |
Data Availability | Value (USD ) |
Segments Covered | Type, End User, and Region |
Regions Covered | North America, South America, Europe, Asia Pacific, Middle East, and Africa |
Fastest Growing Region | Asia-Pacific |
Largest Market Share | North America |
Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and other key Insights.
|
For know more Insights - Download Sample
Market Dynamics
The DNA/RNA extraction kit market growth is driven by the growing funding for R&D of extraction kits, advancement in technology, and increased automation in DNA/RNA extraction technology majorly drive the market. In addition, an increase in demand for user-friendly products boosts the growth of this market.
Growing advancement in technology is expected to drive the growth in the forecast period
Advancement in automation technologies, resulting in more accurate and effective analysis. Global key players have developed many new and broad range of DNA/RNA extraction kits that are fast, accurate and easy to use to analyze microorganisms, animal, food and environmental samples. DNA/RNA extraction kits have been optimized with PCR and electrophoresis equipment for rapid identification and quantification of DNA/RNA samples. The isolated DNA/RNA can be used directly in PCR assays using tailor-made kits that efficiently work with all types of sample matrices. DNA/RNA extraction techniques are performed in hospital laboratories, diagnostic laboratories, academic & research laboratories, biopharmaceutical companies, forensic laboratories and contract research organizations.
Lack of new product awareness coupled with the high cost of nucleic acids extraction kits is expected to hinder the growth in the forecast period
Lack of awareness of products for the scientists and laboratories which is used to complete complicated pathogen and disease screening procedure with a streamlined process, quality results, and leveraged lab efficiency and high cost of kits $5500 is the major factors hampering the market growth.
COVID-19 Impact Analysis
COVID-19 first began in Wuhan (China) in December 2019; it has spread fast across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in confirmed cases and reported deaths. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in the global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America affect business collaborations and partnerships opportunities.
Market Segment Analysis
The cell-free DNA (cfDNA) segment is expected to hold the largest share in this market segment
Cell-free DNA (or cfDNA) refers to all non-encapsulated DNA in the bloodstream. A portion of that cell-free DNA originates from a tumor clone and is called circulating tumor DNA (or ctDNA). cfDNA is nucleic acid fragments that enter the bloodstream during apoptosis or necrosis. These kits tout a simple and automation-friendly protocol that allows users to quickly extract from a range of sample volumes, high-quality downstream ready cfDNA.
The laboratory segment is expected to hold largest share in this market segment
Most labs use commercial DNA extraction kits, which employ spin columns, for the isolation of DNA and RNA. The spin columns contain a silica resin that selectively binds DNA and RNA, depending on the salt conditions and other factors influenced by the extraction method. These account for the largest share of the segment.
Market Geographical Share
North America region holds the largest market share of the global DNA/RNA extraction kit market
North America is anticipated to be the leading regional market for DNA/RNA extraction. Growing genomic and proteomic research along with research collaborations amongst research institutes and hospital laboratories for clinical DNA/RNA data analysis are some of the major developments that will fuel the growth of the DNA/RNA extraction market. The regional North American market for DNA/RNA extraction is also going to be driven by the presence of manufacturing hubs of key companies operating in the DNA/RNA extraction market.
DNA/RNA Extraction Kit Companies
The global DNA/RNA extraction kit market is moderately competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include Thermo Fisher Scientific Inc, Primerdesign, QIAGEN N.V., RevoluGen, Bioneer corp, BioFire Defense, General Biosystems, Akonni Biosystems, Promega Corporation, Bio-Rad Laboratories, and many more. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, in July 2019, RevoluGen, a UK-based small molecular chemistry and research company announced a global distribution collaboration with Merck for its unified high molecular weight DNA extraction and size selection product Fire Monkey / Fire Flower.
Bio-Rad Laboratories
Overview: Bio-Rad, founded in 1952, is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With employees, more than 7,800, headquarters Hercules, California, USA. Bio-Rad is among the top five life science companies globally, providing instruments, software, consumables, reagents, and content for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. It is the world leader in clinical quality control products, services, and information systems, ensuring the accuracy and validity of clinical test results.
Product Portfolio: The Company’s portfolio comprised of include life science research and clinical diagnostics.
The global DNA/RNA extraction kit market report would provide access to an approx. 53 market data table, 46 figures, and 180 pages.